Drug News

Medindia's Press Release’ section provides the latest press release on Drug from across the world for the global audience. This page links to 12850 Drug press releases.

OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry

London, Jan. 30, 2024 (GLOBE NEWSWIRE) -- January 30, 2024, London, UK – OPEN Health has launched  OPEN X Health , a new practice focused on providing data-driven creativity to the pharmaceutical industry. OPEN X Health (OPEN X) ...


Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients

In the Phase 2b trial, 100% (5 of 5) of ibezapolstat-treated patients who agreed to observation for up to three months following Clinical Cure of CDI experienced no recurrence of infection Further analyses will be forthcoming as data become ...

Sionna Therapeutics Announces Phase 1 Initiation for SION-109 in Cystic Fibrosis

- SION-109 is a small molecule targeting the interface between the ICL4 region and the NBD1 domain of the CFTR protein; designed to complement the company's NBD1 modulator portfolio - - First subject dosed in Phase 1 clinical trial - ...

Ascletis Announces Dosing of the First Patient in Phase III Clinical Trial of ASC40 (Denifanstat) for Treatment of Acne

HANGZHOU and SHAOXING, China , Jan. 24, 2024 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces dosing of the first patient in Phase III clinical trial of ASC40 (Denifanstat) for treatment of moderate to ...

Caliway Received First Approval of CBL-514 Pivotal Phase 3 Study Application for Subcutaneous Fat Reduction

NEW TAIPEI CITY , Jan. 23, 2024 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) announces that Australian Bellberry HREC has approved Caliway's application to initiate CBL-514's Pivotal Phase 3 study (CBL-0301 Phase 3) for ...

The European Commission Grants Orphan Drug Designation to NS-229 for the Treatment of Eosinophilic Granulomatosis with Polyangiitis

PARAMUS, N.J. , Jan. 22, 2024 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd, announced today that the European Commission (EC) has granted orphan drug designation to NS-229, which is being developed ...

Synendos Therapeutics AG Granted EMA Clinical Trial Authorisation for first-in-class Endocannabinoid System modulator, SYT-510

Synendos Therapeutics transitions to a clinical-stage biotech company developing innovative Endocannabinoid System (ECS) treatments for neuropsychiatric, neuroinflammatory and other Central Nervous System (CNS) disorders Clinical Trial ...

Orphalan Announces China NMPA's Approval of Its Trientine Tetrahydrochloride Product for the Treatment of Wilson disease

Orphalan announces China NMPA’s approval of its trientine tetrahydrochloride product for the treatment of Wilson disease Paris, France 18 January , 2024 - Orphalan SA (“Orphalan” or “the Company”), an international orphan drug ...

Immunity Pharma Announces Positive Top Line Results from Phase 2a Trial with IPL344 in ALS Patients

Treatment with IPL344 was well tolerated Changes in the slope of decline in ALSFRS-R demonstrated 48% slower disease progression (p=0.028); and 64% slower progression when adjusted for disease stage and rate (p=0.034) Study suggests benefits ...

Fermion announces IND Approval of Non-Addictive Pain Relief Drug FZ008-145 by China NMPA

GUANGZHOU, China , Jan. 10, 2024 /PRNewswire/ -- Guangzhou Fermion Technology Co., Ltd. (Fermion), a clinical-stage AI-based drug discovery company that specializes in developing drugs for autoimmune diseases and pain, has announced today ...

Drug News »

First Recombinant Vaccine for Swine Fever Virus

First Recombinant Vaccine for Swine Fever Virus

Researchers at the Indian Institute of Technology (IIT) Guwahati disclosed the technology transfer for India's inaugural recombinant vaccine against the swine fever virus, facilitating its commercial deployment in pigs and wild boars ...

Birth Control Pill Opill to be Available Over the Counter in USA

Birth Control Pill Opill to be Available Over the Counter in USA

Perrigo’s announcement of Opill (norgestrel) ( ) becoming available over-the-counter marks a milestone as the first daily birth control pill to do so in the US. Opill Promises Expanded Over-the-Counter Oral Contraceptive ...

Ozempic and Wegovy - GLP-1 Agonists Set to Become the Best-selling Drugs in 2024

Ozempic and Wegovy - GLP-1 Agonists Set to Become the Best-selling Drugs in 2024

The rise of GLP-1 agonist drugs, including Ozempic and Wegovy, has reshaped the weight loss and diabetes treatment landscape in 2023. Fueled by promising clinical trial results and...

Can This New Drug Cure Ebola by Targeting Replication?

Can This New Drug Cure Ebola by Targeting Replication?

Ebola virus disease (EVD), caused by several species of viruses belonging to the genus Ebolavirus , is a severe and often fatal illness in humans. It is characterized by symptoms such as fever , severe vomiting, bleeding, and neurological issues. EVD ...

Accelerated FDA Approval of Resmetirom for the Treatment of  MASH/NASH

Accelerated FDA Approval of Resmetirom for the Treatment of MASH/NASH

On March 14, 2024, the FDA announced its accelerated approval of Resmetirom for the treatment of MASH (Metabolic Dysfunction-Associated Steatohepatitis (MASH) that is commonly referred as Non-alcoholic steatohepatitis (NASH). It can be prescribed ...

More Drug News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.